Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials
Journal Name
Communications Medicine
Myasia Chaplin
Wed, 10/14/2026 - 11:01
Primary Author
Platzbecker AS
Author(s)
Zoldan K, Brauer D, Kiewe P, Sasca D, Sockel K, Illmer T, Giagounidis A, Nowak D, Rieger K, Wortmann F, Götze K, Sc...
Want to know the latest news and articles posted on Aplastic Anemia and MDS International Foundation (AAMDSIF)?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: The Aplastic Anemia & MDS International Foundation | Aplastic Anemia and MDS International Foundation (AAMDSIF)